| Texto completo | |
| Autor(es): |
Teixeira Santos, Marcia Cristina
[1]
;
Goncalves Silva, Patricia Benites
[1]
;
Rodini, Carolina Oliveira
[1]
;
Furukawa, Gabriela
[1]
;
Marco Antonio, David Santos
[1]
;
Zanotto-Filho, Alfeu
[2]
;
Moreira, Jose C. F.
[2]
;
Okamoto, Oswaldo Keith
[1]
Número total de Autores: 8
|
| Afiliação do(s) autor(es): | [1] Univ Sao Paulo, Biosci Inst, Dept Genet & Evolutionary Biol, Human Genome & Stem Cell Res Ctr, BR-05508090 Sao Paulo - Brazil
[2] Univ Fed Rio Grande do Sul, Oxidat Stress Res Ctr, Dept Biochem, Porto Alegre, RS - Brazil
Número total de Afiliações: 2
|
| Tipo de documento: | Artigo Científico |
| Fonte: | STEM CELLS AND DEVELOPMENT; v. 24, n. 22, p. 2700-2708, NOV 15 2015. |
| Citações Web of Science: | 4 |
| Resumo | |
Misexpression of stem cell-related genes may occur in some cancer cells, influencing patient's prognosis. This is the case of medulloblastoma, a common and clinically challenging malignant tumor of the central nervous system, where expression of the pluripotency factor, OCT4, is correlated with poor survival. A downstream target of OCT4, L1TD1 (LINE-1 type transposase domain-containing protein 1 family member), encodes a novel embryonic stem cell (ESC)-related protein involved in pluripotency and self-renewal of ESCs. L1TD1 is still poorly characterized and its expression pattern and function in cancer cells are virtually unknown. Although normally restricted to non-neoplastic undifferentiated cells and germ cells, we found that high L1TD1 expression also occurs in medulloblastoma cells, reaching levels similar to those found in ESCs, and is correlated with poor prognosis. Conversely to what is reported during normal cell differentiation, when differentiated cells remain healthy, despite L1TD1 downregulation, depletion of L1TD1 protein levels by targeted gene silencing significantly reduced medulloblastoma cell viability, inhibiting cell proliferation and inducing apoptosis. More strikingly, L1TD1 depletion downregulated expression of the neural stem cell markers, CD133 and Nestin, inhibited neurosphere generation capability, and sensitized medulloblastoma cells to temozolomide and cisplatin, two chemotherapeutic agents of clinical relevance in medulloblastoma treatment. Our findings provide insights about the contribution of pluripotency-related genes to a more aggressive tumor phenotype through their involvement in the acquisition of stem-like properties by cancer cells and point out L1TD1 as a potential therapeutic target in malignant brain tumors. (AU) | |
| Processo FAPESP: | 11/51588-2 - Caracterização funcional da proteína LIN28 no processo de tumorigênese do sistema nervoso central |
| Beneficiário: | Márcia Cristina Teixeira dos Santos |
| Modalidade de apoio: | Bolsas no Brasil - Pós-Doutorado |
| Processo FAPESP: | 11/10001-9 - Contribuição das células-tronco mesenquimais ao desenvolvimento tumoral |
| Beneficiário: | Carolina de Oliveira Rodini |
| Modalidade de apoio: | Bolsas no Brasil - Doutorado |
| Processo FAPESP: | 10/52686-5 - Fator de transcrição E2F2 e expressão de proto-oncogenes em células-tronco embrionárias humanas |
| Beneficiário: | Oswaldo Keith Okamoto |
| Modalidade de apoio: | Auxílio à Pesquisa - Regular |
| Processo FAPESP: | 13/08028-1 - CEGH-CEL - Centro de Estudos do Genoma Humano e de Células-Tronco |
| Beneficiário: | Mayana Zatz |
| Modalidade de apoio: | Auxílio à Pesquisa - Centros de Pesquisa, Inovação e Difusão - CEPIDs |
| Processo FAPESP: | 13/17566-7 - Fator de pluripotência OCT4A e agressividade de meduloblastoma humano |
| Beneficiário: | Patrícia Benites Gonçalves da Silva |
| Modalidade de apoio: | Bolsas no Brasil - Doutorado Direto |